ConductScience.org, home

Paper159309

Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.

Zeller WJ and 2 others. J Cancer Res Clin Oncol, 1979. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222. Papers, record 159309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/159309

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
1.18
iCite
Revised in PubMed
2025-07-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zeller WJW J
2Eisenbrand GG
3Fiebig HHH H

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, ExperimentalMajor topic
Nitrosourea CompoundsMajor topic
Animals
Carmustine
Drug Evaluation, Preclinical
Female
Lomustine
Male
Rats
Semustine
Streptozocin

Source PubMed

Download CSV of topics

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11120307Chemotherapy of the transplantable acute leukemia L5222 in rats.Cancer Res1975https://conductscience.org/library/papers/1120307PubMed
24829828[Leukemia L 5222 of the rat strain BD IX. An ethylnitrosourea-induced monocytic-myeloic transplantable form for cytochemical and chemotherapeutic studies].Blut1974https://conductscience.org/library/papers/4829828PubMed
3122802Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin.J Med Chem1975https://conductscience.org/library/papers/122802PubMed
4954014The nitrosoureas--thoughts for the future.Cancer Treat Rep1976https://conductscience.org/library/papers/954014PubMed
5136102
Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential.
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol1976https://conductscience.org/library/papers/136102PubMed
6621753Chemotherapeutic activity of new 2-chloroethylnitrosoureas in rat L5222 leukemia: comparison of bifunctional and water-soluble derivatives with 1,3-bis(2-chloroethyl)-1-nitrosourea.J Natl Cancer Inst1978https://conductscience.org/library/papers/621753PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
7309781Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.J Cancer Res Clin Oncol1981https://conductscience.org/library/papers/7309781PubMed
6771294Chemotherapy of autochthonous leukemias induced by 7,12-dimethylbenz(a)anthracene in Long Evans rats.J Cancer Res Clin Oncol1980https://conductscience.org/library/papers/6771294PubMed
6470033Antineoplastic activity of esters and amides of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-aminoacids.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6470033PubMed
6227420Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6227420PubMed
3733867Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC).J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3733867PubMed
3700459New derivatives of CNC-amino acids and -oligopeptides: experimental antitumor activity.J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3700459PubMed
3536942DNA adducts and DNA damage by antineoplastic and carcinogenic N-nitrosocompounds.J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3536942PubMed
2930696
Anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine, glycine, their di- and tripeptide homologues and the respective amides in methylnitrosourea-induced rat mammary carcinoma.
Br J Cancer1989https://conductscience.org/library/papers/2930696PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/159309

GET https://conductscience.org/api/papers/v1/159309/authors